Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden.
about
Emergence of a New Highly Successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United KingdomEpidemiology of Invasive Group A Streptococcal Disease in Alaska, 2001 to 2013.Management and Novel Adjuncts of Necrotizing Soft Tissue Infections.Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infectionStreptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles.emm gene diversity, superantigen gene profiles and presence of SlaA among clinical isolates of group A, C and G streptococci from western Norway.Cysteine proteinase SpeB from Streptococcus pyogenes - a potent modifier of immunologically important host and bacterial proteins.Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance.Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece.Emergence of Streptococcus pyogenes emm102 causing toxic shock syndrome in Southern Taiwan during 2005-2012.Evaluation of emm gene types, toxin gene profiles and clonal relatedness of group A streptococciDifferential secretomics of Streptococcus pyogenes reveals a novel peroxide regulator (PerR)-regulated extracellular virulence factor mitogen factor 3 (MF3).Epidemiology of invasive Streptococcus pyogenes infections in France in 2007M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition.Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010.Analysis of a Streptococcus pyogenes puerperal sepsis cluster by use of whole-genome sequencing.Trading Capsule for Increased Cytotoxin Production: Contribution to Virulence of a Newly Emerged Clade of emm89 Streptococcus pyogenesClinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.Streptococcal pharyngitis in children: a meta-analysis of clinical decision rules and their clinical variablesSequence type and emm type diversity in Streptococcus pyogenes isolates causing invasive disease in Norway between 1988 and 2003.Epidemiology of severe Streptococcus pyogenes disease in Europe.Puerperal group a streptococcal infections: a case series and discussion.Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in FinlandClinical and microbiological characteristics of severe Streptococcus pyogenes disease in EuropeIntravenous immunoglobulin in children with streptococcal toxic shock syndrome.Genomic Characteristics Behind the Spread of Bacteremic Group A Streptococcus Type emm89 in Finland, 2004-2014.Current insights in invasive group A streptococcal infections in pediatrics.Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.Severe invasive streptococcal infection by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis.Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US Hospitals.Epidemiology of invasive group A streptococcal infections in Norway 2010-2014: A retrospective cohort study.When should clinicians suspect group A streptococcus empyema in children? A multicentre case-control study in French tertiary care centres.Two unusual cases of severe soft tissue infection caused by Streptococcus dysgalactiae subsp. equisimilisStreptococcus pyogenes emm and T types within a decade, 1996-2005: implications for epidemiology and future vaccines.In vitro imaging of bacteria using 18F-fluorodeoxyglucose micro positron emission tomography.Evaluation and Management of Necrotizing Soft Tissue Infections.Antibiotic susceptibilities, streptococcal pyrogenic exotoxin gene profiles among clinical isolates of group C or G Streptococcus dysgalactiae subsp. equisimilis & of group G S. anginosus group at a tertiary care centre.Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.emm Type distribution pattern of group A streptococcus in north India: need for a new preventive approach.
P2860
Q28383363-DB0E5AA9-5BE2-499A-BAD0-BDE22315AEDDQ30202103-0B5B4024-B341-4213-8E4F-9918A114C845Q30234954-5E82478A-2F13-4EA2-9D5F-C7746CEB251EQ33646539-189BA918-A78A-4F21-8BD9-8A56476384AAQ33704695-F9A16A35-FC65-462E-B390-68884CEAEB64Q34151601-7E9A53DA-4562-4F1B-8814-190EC1B66603Q34229809-6102BD24-954E-4FD7-A80D-F0CD3C7D5A25Q34488366-F198CE62-3AB1-4B44-B7B3-4904E144B465Q34971503-CC7B6184-1FC3-430A-A958-BA33B0B68307Q35069734-5FC1428C-DFFF-4598-936F-80A1E9AFEE07Q35099922-227AD466-0092-414B-9E91-7064ADCA81AEQ35264618-9888DA6E-5F58-4C33-9E50-C9E9128F87D3Q35598886-4E82580C-C654-4D29-BD01-901178B3A55CQ35621805-9FC0EFFC-F1E0-40E4-816F-AD9F38E141C6Q35847191-336E5BAD-564C-465D-9916-CB41093178CDQ36118655-9D839420-F20B-45DC-BE4A-F58C24908916Q36177550-FF26BBC7-436B-492C-94A7-A890295844BAQ36423634-6621088A-325B-4279-8303-F3B156EE1FA4Q36730289-CB8DF342-AC0B-47E9-8FEA-AF6490857F3AQ36747441-FFF29727-4A9E-46EE-B53D-1C346A73705CQ36747672-EF8FAE10-F35B-4F7D-B2D6-F37D1D0CF6E6Q36801648-D6C9D6AE-CCC0-43A7-B590-01B83EFD0CE1Q37040500-113440FA-A99A-48C4-A0A3-A17874B8107AQ37099562-E47C79F7-343E-4AC5-A017-0B7C961439DDQ37156883-19ECBA21-9F71-4F56-9817-5D8F86567A1AQ37387611-88C1136E-F21F-42AF-812C-4D76F0A24D03Q37480632-76953552-FE32-44D3-A5A8-039AD218FA85Q37988376-55E24D96-3127-4E98-8957-B028A740A5EFQ38575717-F1C6456B-506C-4034-9CF1-72550B7966DEQ38695057-4B838F94-5D56-4123-BAC9-C6919ED5013DQ39062640-7B0C41C4-5634-48A1-8334-29C4C35EF5FCQ39677935-B7AEF0F6-003C-4263-85D3-D17ACA5BED48Q39854930-30B65F18-E7C7-4143-AB5B-9A1F15005E18Q39900875-4EC29709-EF1E-482D-BABC-25B395343A47Q39975371-C5F024CF-A680-4480-8621-6C43F4506490Q40048968-A5F0CBE8-9CD6-4DE8-A1F0-B1F5E8F62C12Q40093740-000DC539-75EB-4596-9B79-8E2997096607Q41128661-2038F61C-F524-4437-A872-5DAEB8F967D2Q42210564-30A3880E-94C0-4A2E-8F01-AA8949D4368FQ42739588-536673A4-E59F-4C79-A934-2FE3F276CBA9
P2860
Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Molecular and clinical charact ...... ptococcal infection in Sweden.
@en
Molecular and clinical charact ...... ptococcal infection in Sweden.
@nl
type
label
Molecular and clinical charact ...... ptococcal infection in Sweden.
@en
Molecular and clinical charact ...... ptococcal infection in Sweden.
@nl
prefLabel
Molecular and clinical charact ...... ptococcal infection in Sweden.
@en
Molecular and clinical charact ...... ptococcal infection in Sweden.
@nl
P2093
P356
P1476
Molecular and clinical charact ...... ptococcal infection in Sweden.
@en
P2093
Aftab Jasir
Anna Norrby-Teglund
Birgitta Henriques Normark
Bogdan Luca-Harari
Claes Schalén
Helena Pettersson
Jessica Darenberg
Mari Norgren
Victoria Romanus
P304
P356
10.1086/519936
P407
P577
2007-07-10T00:00:00Z